EXPONENT INC (EXPO) Form 8-K — Oct 29, 2026
$EXPOForm 8-KItems 2.02, 7.01, 9.01Filed Oct 29, 2026, 4:05 PM ET0001171843-26-006972Original filing
Exponent (EXPO) reported strong Q3 2026 results, with revenues before reimbursements up 12% to $153.1 million and diluted EPS rising to $0.64 from $0.55 a year ago. Management raised full-year 2026 guidance, now expecting revenues before reimbursements to grow 10-11% with EBITDA margins of 28.0-28.3%, citing 77% utilization and demand in user research and dispute-related work.
Key figures
- Eps
- 0.64
- Revenue
- 173733000
- Guidance
- Q4 2026 revenues before reimbursements to grow 8-10%, EBITDA 26.3-26.8% of revenues before reimbursements; full-year 2026 revenue growth raised to 10-11%, EBITDA margin 28.0-28.3%
- Net Income
- 30943000
- Revenue Yoy
- 18% total revenues; 12% revenues before reimbursements
- Total Assets
- 693076000
- Cash Position
- 114689000
- Ebitda q3
- 44976000
- Utilization
- 77%
- Ytd buybacks
- 146100000
- Ytd net income
- 89907000
- Ytd diluted eps
- 1.83
- Ebitda margin q3
- 29.4%
- Dividend per share
- 0.31
- Ytd dividends paid
- 46100000
- Dividend record date
- 2026-12-04
- Dividend payment date
- 2026-12-18
- Engineering segment share
- 85%
- Environmental segment share
- 15%
- Ytd revenues before reimbursements
- 453740000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.